Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CAO Amir Cohen sold 10,300 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $5.79, for a total value of $59,637.00. Following the completion of the sale, the chief accounting officer directly owned 191,838 shares of the company’s stock, valued at approximately $1,110,742.02. This represents a 5.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Amir Cohen also recently made the following trade(s):
- On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The stock was sold at an average price of $5.91, for a total transaction of $239,798.25.
Strata Critical Medical Price Performance
NASDAQ SRTA opened at $6.26 on Thursday. Strata Critical Medical has a 1-year low of $3.40 and a 1-year high of $6.29. The firm has a market capitalization of $541.66 million, a P/E ratio of -78.25 and a beta of 2.15. The stock has a fifty day moving average of $4.88.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on SRTA shares. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. B. Riley Financial started coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price target on the stock. Finally, Craig Hallum started coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Strata Critical Medical currently has an average rating of “Moderate Buy” and an average price target of $8.00.
View Our Latest Analysis on Strata Critical Medical
Institutional Investors Weigh In On Strata Critical Medical
A number of large investors have recently bought and sold shares of SRTA. Granite Investment Partners LLC boosted its holdings in Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after purchasing an additional 7,911 shares in the last quarter. Seelaus Asset Management LLC boosted its holdings in Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after purchasing an additional 6,000 shares in the last quarter. Principal Financial Group Inc. bought a new stake in Strata Critical Medical in the first quarter worth $537,000. Quantinno Capital Management LP boosted its holdings in Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after purchasing an additional 71,155 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in Strata Critical Medical by 16.2% in the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after purchasing an additional 25,379 shares in the last quarter. 47.36% of the stock is currently owned by institutional investors.
Strata Critical Medical Company Profile
Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than Strata Critical Medical
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Strata Critical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Critical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
